WeVote
Log In

Bill

Bill

A 1522

Requires the office of addiction services and supports to encourage, aid, and facilitate clinical research into the use of ibogaine in drug treatment

2025 Regular Session Introduced by Keith Brown and 2 co-sponsors

Bill A 1522 promotes clinical research on ibogaine for drug addiction treatment, aiming to provide new options for those struggling with substance use disorders.

REFERRED TO ALCOHOLISM AND DRUG ABUSE
0
WeVote Research Nonpartisan
Bill Summary · A 1522

Summary of Bill A 1522

Bill Information

  • Bill Number: A 1522
  • Title: Requires the office of addiction services and supports to encourage, aid, and facilitate clinical research into the use of ibogaine in drug treatment
  • Status: Referred to Alcoholism and Drug Abuse
  • Introduced: January 10, 2025
  • Classification: Bill

Purpose and Intent

Bill A 1522 aims to promote clinical research into the use of ibogaine as a treatment for drug addiction. Ibogaine is a naturally occurring psychoactive substance that has shown potential in reducing withdrawal symptoms and cravings associated with various substance use disorders. The bill seeks to empower the office of addiction services and supports to take an active role in facilitating this research.

Key Provisions

  • Encouragement of Research: The bill mandates the office of addiction services and supports to actively encourage and aid in clinical research focused on ibogaine.
  • Facilitation of Studies: The office will facilitate the establishment of clinical trials and studies to evaluate the efficacy and safety of ibogaine in treating addiction.
  • Collaboration with Researchers: The bill promotes collaboration between state agencies, research institutions, and healthcare providers to advance understanding of ibogaine's potential benefits in addiction treatment.

Impact

  • Target Population: The primary beneficiaries of this bill would be individuals struggling with substance use disorders who may benefit from alternative treatment options, particularly those who have not found success with traditional therapies.
  • Healthcare Providers and Researchers: The bill would also impact healthcare providers and researchers by providing a framework for conducting studies on ibogaine, potentially leading to new treatment protocols and guidelines.
  • State Addiction Services: The office of addiction services and supports will play a crucial role in overseeing and promoting this research, which may lead to changes in state policies regarding addiction treatment.

Procedural Aspects

  • Current Status: As of January 10, 2025, the bill has been referred to the Alcoholism and Drug Abuse committee for further consideration.
  • Related Legislation: This bill is related to prior-session Bill A 6210 and has a companion bill, S 1817, which may address similar issues or complement the objectives of A 1522.

Conclusion

Bill A 1522 represents a significant step towards exploring innovative treatment options for drug addiction through clinical research on ibogaine. By facilitating studies and encouraging collaboration, the bill aims to enhance the understanding and application of this substance in addiction treatment, potentially offering new hope for individuals facing substance use disorders.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.